Medical Research Finder

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Inflammatory Bowel Disease (IBD) & Interleukin-10 (IL-10)

Navigation

Contents

Some cytokines that play a prominent role in the pathogenesis of patients with Inflammatory Bowel Disease (IBD), such as interleukin-10 and IL-17, do not have effective targeting agents
Marafini et al. 2019 Expert Opin Biol Ther 19: 1207-17
Moschen et al. 2019 Nat Rev Gastroenterol Hepatol 16: 185-96

see also:
Chronic infection
Colitis / Intestinal Inflammation & Interleukin-10 (IL-10)
Interleukin-10 (IL-10)

References (Sources)

IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease
Zhu et al. 2017 Gastroenterology Res 10: 65-69
Review
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Moschen et al. 2019 Nat Rev Gastroenterol Hepatol 16: 185-96
Review
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor
Glocker et al. 2009 N Engl J Med 361: 2033-2045
Inflammatory cytokines: from discoveries to therapies in IBD
Marafini et al. 2019 Expert Opin Biol Ther 19: 1207-17
Review

AI Chat

5/29/2026

Chat with our artificial intelligence: